Home
Explore Technologies
Stanford OTL
The Office of Technology Licensing was established in 1970 to transfer technologies developed at Stanford. Find out more about OTL's history, mission, staff, and statistics.
Contact
|
Explore Technologies
H11 and 2F3 cell line
Stanford Reference:
13-001
Abstract
Researchers in Dr. Shoshana Levy’s lab have created a pro B cell lines that provides the first B cell lineage tumors in a C57BL mouse strain. The cell lines, known as H11 and 2F3, were made by transducing mouse bone marrow with BCR-ABL retrovirus. The H11 and 2F3 cell lines may be used in immunotherapy and tumor biology research.
Stage of research
The H11 cell line has been used to develop a whole tumor cell vaccine in adoptive cell therapy studies.
Applications
Tumor biology
Immunology
Advantages
First B cell lineage tumors in C57BL strain of mouse
Grows in tissue culture
Transplantable in syngeneic mice
Cell line is MHC class II negative
Cells can be loaded with reagents and labeled for visualization
Can isolate ample numbers of these cells to prepare vaccine
Publications
Goldstein MJ, Varghese B, Brody JD, Rajapaksa R, Kohrt H, Czerwinski DK, Levy S, Levy R.
A CpG-loaded tumor cell vaccine induces antitumor CD4+ T cells that are effective in adoptive therapy for large and established tumors.
Blood. 2011 Jan 6;117(1):118-27. doi: 10.1182/blood-2010-06-288456. Epub 2010 Sep 27.
Goldstein MJ, Kohrt HE, Houot R, Varghese B, Lin JT, Swanson E, Levy R.
Adoptive cell therapy for lymphoma with CD4 T cells depleted of CD137-expressing regulatory T cells.
Cancer Res. 2012 Mar 1;72(5):1239-47. doi: 10.1158/0008-5472.CAN-11-3375. Epub 2012 Jan 9.
Building of teh tetraspanin web: distinct structural domains of CD81function in different cellular compartmens. Mol Cell Biol. 2006 Feb; 26(4):1373-85
Related Web Links
Levy lab
Innovators & Portfolio
Matthew Goldstein
Shoshana Levy
more technologies from Shoshana Levy »
Date Released
12/19/2014 12:00
Licensing Contact
Michael Bellas, Licensing Associate
Request Info
79-066
Mouse Anti-Human Hybridomas: 12E7, L243, L17F12, L368
82-068
Hybridomas 3B12, an Anti-Human Leucocyte Reagent, and Hybridoma 4H9, an Anti-Human T Cell Reagent
83-007
Anti-Leu-12 (CD19) Monoclonal Antibody, 4G7
more technologies »
Related Keywords
B-cell immunology
cancer vaccine
cancer: lymphoma
LS: research tool: cell line
LS: research tool: reagent
research: cancer
tumor immunology